120 related articles for article (PubMed ID: 30511560)
1. Prognostic significance of expression of myogenin and OCT4 in glioma.
Zheng N; Zhang D; Liu X
Minerva Pediatr (Torino); 2023 Aug; 75(4):544-549. PubMed ID: 30511560
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA AFAP1-AS1 accelerates invasion and predicts poor prognosis of glioma.
Wang Y; Lan Q
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5223-5229. PubMed ID: 30178845
[TBL] [Abstract][Full Text] [Related]
3. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
[TBL] [Abstract][Full Text] [Related]
4. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
Wang Y; Zhao W; Liu X; Guan G; Zhuang M
J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
[TBL] [Abstract][Full Text] [Related]
5. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
Ding D; Song T; Jun W; Tan Z; Fang J
Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530
[TBL] [Abstract][Full Text] [Related]
7. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
8. Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.
Meng Q; Luo G; Liu B; Sun Y; Yan Z
Neoplasma; 2018; 65(4):604-609. PubMed ID: 30064232
[TBL] [Abstract][Full Text] [Related]
9. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
Li X; Zheng J; Chen L; Diao H; Liu Y
Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291
[TBL] [Abstract][Full Text] [Related]
10. Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis.
Jin Y; Xiao W; Song T; Feng G; Dai Z
Neurochem Res; 2016 Jul; 41(7):1723-31. PubMed ID: 27038932
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients.
Men D; Liang Y; Chen L
Cancer Epidemiol; 2014 Apr; 38(2):152-6. PubMed ID: 24559637
[TBL] [Abstract][Full Text] [Related]
13. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas.
Liu Z; Cheng X; Lin S; Han Z; Jin H; Luan Z; Li P; Liang W; Qian R; Gao Y
Cell Mol Neurobiol; 2023 Jan; 43(1):409-422. PubMed ID: 35106666
[TBL] [Abstract][Full Text] [Related]
15. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
16. Impact of a novel biomarker, T-LAK cell-originating protein kinase (TOPK) expression on outcome in malignant glioma.
Hayashi T; Hayakawa Y; Koh M; Tomita T; Nagai S; Kashiwazaki D; Sugimori M; Origasa H; Kuroda S
Neuropathology; 2018 Apr; 38(2):144-153. PubMed ID: 29271010
[TBL] [Abstract][Full Text] [Related]
17. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
[TBL] [Abstract][Full Text] [Related]
18. RGS16 promotes glioma progression and serves as a prognostic factor.
Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
[TBL] [Abstract][Full Text] [Related]
19. Calponin 3 Acts as a Potential Diagnostic and Prognostic Marker and Promotes Glioma Cell Proliferation, Migration, and Invasion.
Xie Y; Ding W; Xiang Y; Wang X; Yang J
World Neurosurg; 2022 Sep; 165():e721-e731. PubMed ID: 35792226
[TBL] [Abstract][Full Text] [Related]
20.
Qu S; Liu J; Wang H
Front Immunol; 2021; 12():648416. PubMed ID: 33889156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]